Cui Cui
Stock Analyst at Jefferies
(4.44)
# 1,171
Out of 4,966 analysts
35
Total ratings
60.6%
Success rate
32.2%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $45.00 → $60.00 | $47.00 | +27.66% | 2 | Aug 27, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Reiterated: Buy | $15.50 → $30.00 | $32.36 | -7.29% | 2 | Aug 20, 2026 | |
| HKG: 6618 JD Health International Inc. | Reiterated: Buy | $88.00 → $80.00 | $34.74 | +130.28% | 4 | Aug 17, 2026 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Reiterated: Buy | $8.00 → $5.30 | $3.02 | +75.50% | 2 | May 19, 2026 | |
| HKG: 9966 Alphamab Oncology | Reiterated: Buy | $9.60 | $7.97 | +20.45% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Reiterated: Hold | $12.40 | $6.13 | +102.45% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $226.00 | $90.30 | +150.28% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $500.00 | $168.70 | +196.38% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $300.00 → $520.00 | $465.20 | n/a | 3 | Aug 19, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Sell | $5.00 | $8.71 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41.00 → $60.00 | $72.10 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175.00 → $87.40 | $188.80 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 | $93.55 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.00 | $2.10 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.80 | $6.93 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.00 | $15.36 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110.00 | $41.40 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 → $35.20 | $20.78 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.00 → $25.00 | $32.72 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $15.44 | n/a | 1 | Apr 22, 2020 |
WuXi Biologics (Cayman) Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $45.00 → $60.00
Current: $47.00
Upside: +27.66%
Genscript Biotech Corporation
Aug 20, 2026
Reiterated: Buy
Price Target: $15.50 → $30.00
Current: $32.36
Upside: -7.29%
JD Health International Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $88.00 → $80.00
Current: $34.74
Upside: +130.28%
Alibaba Health Information Technology Limited
May 19, 2026
Reiterated: Buy
Price Target: $8.00 → $5.30
Current: $3.02
Upside: +75.50%
Alphamab Oncology
Mar 27, 2026
Reiterated: Buy
Price Target: $9.60
Current: $7.97
Upside: +20.45%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Reiterated: Hold
Price Target: $12.40
Current: $6.13
Upside: +102.45%
Akeso, Inc.
Oct 19, 2025
Reiterated: Buy
Price Target: $226.00
Current: $90.30
Upside: +150.28%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Reiterated: Buy
Price Target: $500.00
Current: $168.70
Upside: +196.38%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Reiterated: Buy
Price Target: $300.00 → $520.00
Current: $465.20
Upside: n/a
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Reiterated: Sell
Price Target: $5.00
Current: $8.71
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $41.00 → $60.00
Current: $72.10
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $175.00 → $87.40
Current: $188.80
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $40.00
Current: $93.55
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $4.00
Current: $2.10
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $10.80
Current: $6.93
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $26.00
Current: $15.36
Upside: n/a
Oct 31, 2023
Reiterated: Buy
Price Target: $110.00
Current: $41.40
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $40.00 → $35.20
Current: $20.78
Upside: n/a
Sep 4, 2023
Reiterated: Buy
Price Target: $28.00 → $25.00
Current: $32.72
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $15.44
Upside: n/a